The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with a pragmatic approach to innovation in healthcare, the successful candidate is regarded as a leader with the ability to think conceptually, making him a valuable member of the team at Genmab. The new Vice President joined the Genmab team earlier this month and is already engaged in designing, developing, and implementing the informatics and computational biology arm of the Translational Research Department.The Chase Group proudly connects life-changing companies with executives and would like to congratulate Genmab on securing such a high caliber talent for their team. We value our continued partnership, helping Genmab in their mission to create and develop differentiated antibody therapeutics for the treatment of cancer.
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with a pragmatic approach to innovation in healthcare, the successful candidate is regarded as a leader with the ability to think conceptually, making him a valuable member of the team at Genmab. The new Vice President joined the Genmab team earlier this month and is already engaged in designing, developing, and implementing the informatics and computational biology arm of the Translational Research Department.The Chase Group proudly connects life-changing companies with executives and would like to congratulate Genmab on securing such a high caliber talent for their team. We value our continued partnership, helping Genmab in their mission to create and develop differentiated antibody therapeutics for the treatment of cancer.
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. -
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… 
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…